HIV Research milestone

 A kashmiri young scientist has proved himself by creating a milestone in HIV research.In what could turn out to be a game changer in
the fight against AIDS, a team of scientists from
The Scripps Research Institute (TSRI) have made
a vital progress in the field of antibody-based
HIV vaccine development, a study has shown.
Kashmir-born Raiees Andrabi is the first author
of a study published on Nov 17 as the cover
article of the journal Immunity that describes four
prototype antibodies that target a specific weak
spot on the virus.
With the help of these antibodies, the
researchers mimicked the molecular structure of
a protein on HIV when designing their own
potential HIV vaccine candidate.
“This study is an example of how we can learn
from natural infection and translate that
information into vaccine development,” said
TSRI Research Associate Raiees Andrabi, as
reported by eurekaalert.Org. “This is an
important advance in the field of antibody-
based HIV vaccine development.”
In addition to Andrabi, Dennis Burton was the
senior author of the study “Identification of
Common Features in Prototype Broadly
Neutralizing Antibodies to HIV Envelope V2
Apex to Facilitate Vaccine Design.”
James E Voss, Chi-Hui Liang, Bryan Briney,
Laura E McCoy of TSRI, IAVI and CHAVI-ID;
Pascal Poignard of TSRI and IAVI; and Chung-Yi
Wu and Chi-Huey Wong of the Genomics
Research Center, Academia Sinica and TSRI
were the other authors.